Education
About Us
Working with TipRanks
Follow Us
Scinai Immunotherapeutics (SCNI)
NASDAQ:SCNI
SCNI Stock Chart & Stats
$0.94
-$0.11(-3.01%)
At close: 4:00 PM EST
$0.94
-$0.11(-3.01%)
Day’s Range― - ―
52-Week Range$0.86 - $6.18
Previous CloseN/A
Volume8.73K
Average Volume (3M)101.31K
Market Cap
$963.88K
Enterprise Value$8.60M
Total Cash (Recent Filing)$989.00K
Total Debt (Recent Filing)$2.36M
Price to Earnings (P/E)0.2
Beta1.15
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,187,679
10 Day Avg. Volume127,573
30 Day Avg. Volume101,310
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.27
Price to Sales (P/S)4.11
P/FCF Ratio-0.43
Enterprise Value/Market Cap8.92
Enterprise Value/Revenue7.49
Enterprise Value/Gross Profit-5.10
Enterprise Value/Ebitda0.98
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Scinai Immunotherapeutics News
SCNI FAQ
What was Scinai Immunotherapeutics’s price range in the past 12 months?
Scinai Immunotherapeutics lowest stock price was $0.86 and its highest was $6.18 in the past 12 months.
What is Scinai Immunotherapeutics’s market cap?
Scinai Immunotherapeutics’s market cap is $963.88K.
When is Scinai Immunotherapeutics’s upcoming earnings report date?
Scinai Immunotherapeutics’s upcoming earnings report date is May 07, 2026 which is in 159 days.
How were Scinai Immunotherapeutics’s earnings last quarter?
Currently, no data Available
Is Scinai Immunotherapeutics overvalued?
According to Wall Street analysts Scinai Immunotherapeutics’s price is currently Overvalued.
Does Scinai Immunotherapeutics pay dividends?
Scinai Immunotherapeutics does not currently pay dividends.
What is Scinai Immunotherapeutics’s EPS estimate?
Scinai Immunotherapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scinai Immunotherapeutics have?
Scinai Immunotherapeutics has 3,187,679 shares outstanding.
What happened to Scinai Immunotherapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Scinai Immunotherapeutics?
Currently, no hedge funds are holding shares in SCNI
Company Description
Scinai Immunotherapeutics
Scinai Immunotherapeutics (SCNI) is a biopharmaceutical company focused on the development and commercialization of novel immunotherapeutic products. Operating within the biotechnology and healthcare sectors, SCNI specializes in creating innovative treatments aimed at harnessing the body's immune system to combat various diseases. The company is dedicated to advancing its pipeline of proprietary immunotherapy candidates, addressing critical unmet medical needs across a range of indications.
Technical Analysis
GT Biopharma
―
Aditxt
―
CERo Therapeutics Holdings
―
Psyence Biomedical
―
Conduit Pharmaceuticals
―
Ownership Overview
―
Insiders
0.46% Other Institutional Investors
99.54% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---